MIRA Pharmaceuticals Reports SKNY-1 Reduced Weight and Fat in Obese Mice Study
The headline reports that oral SKNY-1 reduced weight and fat in obese mice; no further study details are provided.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MIRA Pharmaceuticals Reports SKNY-1 Weight and Fat Reduction in Obese Mice
MIRA Pharmaceuticals reported that oral SKNY-1 significantly reduced weight and fat in obese mice, with favorable lean-mass and weight-regain findings versus semaglutide.